Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

Ampersand Capital Partners buys Purna Pharmaceuticals 

Ampersand Capital Partners, a life sciences and healthcare-focused private equity firm, has acquired Purna Pharmaceuticals, a Belgian contract development and manufacturing service provider (CDMO) for liquid and semi-solid medicines for pharmaceutical companies, from alternative investment fund manager Creafund.
February 19, 2026

CMA issues hold-separate orders on Welltower’s UK care home acquisitions

The UK Competition and Markets Authority (CMA) has ordered US healthcare REIT Welltower to pause the integration process for the 600+ UK care homes it bought in October 2025, as it considers whether controlling all three of the largest for-profit players in the market might raise competition concerns.
February 12, 2026

Siegfried acquires Noramco, Extractas Biosciences, and Purisys from SK Capital

Siegfried, a Switzerland-headquartered pharma Contract Development and Manufacturing Organisation (CDMO), is acquiring three businesses from private equity firm SK Capital: the pharma company Normaco Group, Purisys, a CDMO partner for custom APIs, and Extractas Bioscience, a Tasmania-based botanicals manufacturer.
February 5, 2026

Gilde Healthcare-backed medtech group acquires Rudischhauser 

Netherlands-based thematic healthcare investor Gilde Healthcare has acquired Rudischhauser, a Germany-based surgical instruments and implants contract manufacturer, through its specialist contract manufacturing group for surgical instruments, Surgical Precision Instruments (SPI). 
January 29, 2026

Greek bank Piraeus interested in Bioiatriki to form integrated payor-provider

Piraeus, Greece’s largest bank, has approached Bioiatriki, Greece’s largest for-profit primary care group, with the intention of acquiring it and integrating it with the insurer it bought last year, Ethniki Insurance, to form a major payor-provider which would become the largest for-profit healthcare provider in the country. 
January 27, 2026

Australian competition authority reviewing Ramsay’s acquisition of NCPH from Healthscope

The Australian Competition and Consumer Commission (ACCC) is reviewing the acquisition by Australia’s largest for-profit hospital group, Ramsay Health Care, of Canberra-based National Capital Private Hospital (NCPH), the biggest asset that is being sold off in the liquidation of Healthscope, which was Australia’s second largest hospital group until it went bust last year.
January 26, 2026
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us